Defining dose-limiting toxicity for phase 1 trials of molecularly targeted agents: Results of a DLT-TARGETT international survey-Reference-Cited by-同舟云学术

Defining dose-limiting toxicity for phase 1 trials of molecularly targeted agents: Results of a DLT-TARGETT international survey

Published:2014-08 Issue:12 Volume:50 Page:2050-2056
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Paoletti Xavier,Le Tourneau Christophe,Verweij Jaap,Siu Lillian L.,Seymour Lesley^ORCID,Postel-Vinay Sophie,Collette Laurence,Rizzo Elisa,Ivy Percy^ORCID,Olmos David,Massard Christophe,Lacombe Denis,Kaye Stan B.,Soria Jean-Charles

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference15 articles.

1. Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience;Molife;Ann Oncol,2012

2. Phase I trials of molecularly targeted agents: should we pay more attention to late toxicities?;Postel-Vinay;J Clin Oncol,2011

3. Phase I studies of drug combinations;Verweij;J Clin Oncol,2010

4. Adherence to imatinib therapy in patients with gastrointestinal stromal tumors;Blay;Cancer Treat Rev,2014

5. Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study;Wigertz;Breast Cancer Res Treat,2012

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART;European Journal of Cancer;2024-09

2. Meta‐analyses of phase I dose‐finding studies: Application for the development of protein kinase inhibitors in oncology;Research Synthesis Methods;2024-08-05

3. MC-Keyboard: A Practical Phase I Trial Design for Targeted Therapies and Immunotherapies Integrating Multiple-Grade Toxicities;Journal of Immunotherapy and Precision Oncology;2024-08-01

4. Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents;Journal of Chemotherapy;2024-01-05

5. Estimands in Oncology Early Clinical Development: Assessing the Impact of Intercurrent Events on the Dose-Toxicity Relationship;Statistics in Biopharmaceutical Research;2023-12-18